Partner News: Progenity Raises $125M in Series B Financing to Advance Dx-Rx Platform for GI Tract

Progenity said today it has raised $125 million in Series B financing toward expanding its focus beyond women’s health by accelerating the development of its precision diagnostics and therapeutics platform for the gastrointestinal (GI) tract.

To read more, please click: https://www.clinicalomics.com/articles/progenity-raises-125m-in-series-b-financing-to-advance-dx-rx-platform-for-gi-tract/1327